Technology
Health
Biotechnology
Organovo
$1.089876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.03 (-2.70%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Organovo and other stocks, options, ETFs, and crypto commission-free!
About
Organovo Holdings, Inc. Common Stock, also called Organovo, is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. Read More It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.
Employees
75
Headquarters
San Diego, California
Founded
2012
Market Cap
127.19M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
737.61K
High Today
$1.13
Low Today
$1.07
Open Price
$1.10
Volume
588.16K
52 Week High
$2.09
52 Week Low
$0.90
Collections
Technology
Health
Biotechnology
Medical
Pharmaceutical
US
North America
News
MarketBeatMar 3
Stock Price, News, & Analysis for Organovo
Organovo Holdings, Inc., a biotechnology company, provides therapeutic and drug profiling capabilities based on its 3D bioprint tissues that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissu...
Simply Wall StFeb 20
What You Must Know About Organovo Holdings, Inc.’s (NASDAQ:ONVO) Beta Value
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Anyone researching Organovo Holdings, Inc. (NASDAQ:ONVO) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The other type, which cannot ...
Price Paid on Robinhood
42% Lower
Right Now
52 Week Low
$0.90
Average Price Paid
$1.85
52 Week High
$2.09
Earnings
-$0.10
-$0.08
-$0.07
-$0.05
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected May 30, After Hours